HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

Advancements and Projections in the Global Cardiac Rhythm Management Devices Market: Insights, Trends, Opportunities, and ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five clinical sites. The Company believes the study's findings support the clinical ...

Acknowledging the role of technology, health experts and cardiologists believe that even a minor change in the heart beat, ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

Stopping blood thinners before or during surgery for a CIED may result in little to no difference in undesirable outcomes such as blood clots or bleeding events when compared to taking them ...

NOX2 influences the activity of several key proteins that regulate the heart's rhythm. It also contributes to oxidative ...

Jim Harbaugh has a busy offseason ahead of him. Here's what to know about his heart condition, cardiac ablations and recovery ...

When someone's heart stops pumping, early CPR can save their life. New survey research from the American Heart Association ...

The cardiac pacemaker market has witnessed significant growth over recent years, driven by the increasing prevalence of heart diseases, advancements in pacemaker technology, and growing awareness ...

"The integration of Lucia into UpBeat.org aligns perfectly with our mission to provide innovative resources for patients and ...

Much has changed since the 2013 document came out, with new information on pacing devices, techniques, and more.